⌘K

Login Start Free

Home/Filings/4/0001193125-26-004776

4//SEC Filing

Corvese Brian 4

Accession 0001193125-26-004776

CIK 0001840229other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:21 PM ET

Size

5.3 KB

Accession

0001193125-26-004776

Insider Transaction Report

Form 4

Period: 2026-01-02

MiNK Therapeutics, Inc.INKT

Director

Transactions

Award
Stock Option (Right to Buy)
2026-01-02+5,395→ 5,395 total
Exercise: $11.12Exp: 2036-01-02→ Common Stock (5,395 underlying)

Footnotes (1)

[F1]Option vests on February 2, 2026, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

MiNK Therapeutics, Inc.

CIK 0001840229

Entity typeother

Related Parties

1

filerCIK 0001393207

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 5:21 PM ET
Size: 5.3 KB

View on SEC.gov